Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update
Our analysis highlights the substantial variability in MedDRA coding that may affect the reliability of drug safety analyses. Moreover, studies conducted on PV databases do not sufficiently assess the relevance of query criteria and their impact on the results. We propose a few practical recommendations.
Authors
- Romane Freppel
- Aurélie Grandvuillemin
- Jean‐Luc Faillie
- Adeline Benis
- Philippe Bonniaud
Institutions
- Inserm (FR)
- Université de Bourgogne (FR)
- Université de Montpellier (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- CHU Dijon Bourgogne (FR)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1002/bcp.70483
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00